IL17A and ulcerative colitis: It was found that AhR inhibits IL-17-mediated inflammatory response through negative feedback loops, thus inhibiting the occurrence and development of Ulcerative colitis (UC) (62), and the activation of the AHR can suppress allergic sensitization by suppressing the absolute number of precursor and effector T cells and affecting DCs (63).